Bill Information > SB 6302
Search for another bill or initiative:
SB 6302 - 2007-08
Establishing standards for prescription drug marketing and disclosure.
Sponsors: Kohl-Welles, Keiser, Fairley, Kline, Franklin, Regala
Bill History

2008 REGULAR SESSION

Jan 11
Prefiled for introduction.
Jan 14
First reading, referred to Health & Long-Term Care. (View Original Bill)
Jan 17
Public hearing in the Senate Committee on Health & Long-Term Care at 10:00 AM. (Committee Materials)
Jan 24
Executive action taken in the Senate Committee on Health & Long-Term Care at 10:00 AM. (Committee Materials)
Jan 25
HEA - Majority; 1st substitute bill be substituted, do pass. (View 1st Substitute) (Majority Report)
And refer to Ways & Means.
Minority; do not pass. (Minority Report)
Referred to Ways & Means.
Feb 11
Public hearing in the Senate Committee on Ways & Means at 1:30 PM. (Committee Materials)
Feb 12
Executive action taken in the Senate Committee on Ways & Means at 1:30 PM. (Committee Materials)
WM - Majority; 2nd substitute bill be substituted, do pass. (View 2nd Substitute) (Majority Report)
Minority; without recommendation. (Minority Report)
Passed to Rules Committee for second reading.
Feb 14
Placed on second reading by Rules Committee.
Feb 29
Senate Rules "X" file.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
Available Videos